• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Device Problems Migration or Expulsion of Device (1395); Activation Failure (3270)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/06/2017
Event Type  malfunction  
Manufacturer Narrative
Almandoz, j.E., kayan, y., tenreiro, a., wallace, a.N., scholz, j.M., fease, j.L.,.Tenreiro-picón, o.(2017).Clinical and angiographic outcomes in patients with intracranial aneurysms treated with the pipeline embolization device: intra-procedural technical difficulties, major morbidity, and neurological mortality decrease significantly with increased operator experience in device deployment and patient management.Neuroradiology, 59(12), 1291-1299.Doi.Org/10.1007/s00234-017-1930-z the pipeline device will not be returned for evaluation as they were implanted in the patients.The devices was not returned; the events described in this article could not be confirmed.The cause of the events could not be conclusively determined from the provided information.Mdrs related to this article: 2029214-2018-00220 2029214-2018-00221 2029214-2018-00222 2029214-2018-00223 2029214-2018-00224.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic literature review found reports of technical difficulty during pipeline procedures.The purpose of this article was to determine whether outcomes after pipeline (ped) treatment improve with operator experience.The authors retrospectively reviewed 140 patients who underwent 150 ped procedures to treat 167 intracranial aneurysms.Of the patients, 109 were women and 31 were men; the mean age was 55.4 years.The article states that intraprocedural difficulties included four successfully bridged intra-aneurysmal ped herniations and four ped stenoses requiring balloon angioplasty.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE EMBOLIZATION DEVICE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9496801224
MDR Report Key7366023
MDR Text Key103528982
Report Number2029214-2018-00220
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100018.S004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 03/23/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/23/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/27/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-